Subscribe: Market Wire - Medical and Healthcare: Surgery and Treatments
http://img.marketwire.com/rss/mwMHSU.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  company  health  healthcare  jan  january  marketwired jan  marketwired january  marketwired  medical  new  otcqb  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Surgery and Treatments

Marketwired - Surgery and Treatments



Marketwired - Surgery and Treatments



Last Build Date: Tue, 24 Jan 2017 14:03:59 EST

Copyright: Copyright: (C) Marketwired
 



SFI Foundation Inc. Rolls Out New Stealth Marked Labels

Tue, 24 Jan 2017 13:15:54 EST

HOFFMAN ESTATES, IL--(Marketwired - Jan 24, 2017) -  Wellness Center USA, Inc. (OTCQB: WCUI), today announced that its wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, working with SFI Foundation, Inc. (SFI), a non-profit organization established to issue and administer standards for the quality assurance of specialty performance and racing equipment, has rolled out the first of SFI's new label designs for the 2017 racing season, all of which are marked with Stealth MarkT Intelligent Microparticles or "Stealth Marked" for future authentication.




Three Finalists Named for the 2017 $100,000 Hearst Health Prize in Partnership With the Jefferson College of Population Health

Tue, 24 Jan 2017 12:00:00 EST

NEW YORK, NY and PHILADELPHIA, PA--(Marketwired - January 24, 2017) - Hearst Health, a division of Hearst, and the Jefferson College of Population Health of Thomas Jefferson University, today announced the three finalists for the 2017 Hearst Health Prize, an annual $100,000 award given in recognition of an organization's or individual's outstanding achievement in managing or improving health in the U.S. The announcement was made by Gregory Dorn, MD, MPH, president of Hearst Health, and David B. Nash, MD, MBA, dean of the Jefferson College of Population Health, who is also one of the judges.




Trelleborg Showcases Innovation in Engineered Coated Fabrics for Medical Applications at MD&M West

Tue, 24 Jan 2017 11:45:00 EST

Explore our solutions at MD&M West 2017 Conference (Booth 1605) comprising optimized substrates, coatings and technology




Trelleborg Advances Contract Manufacturing Services for Drug-Device Combination Products

Tue, 24 Jan 2017 10:30:00 EST

Stop by Trelleborg Sealing Solutions Booth 1605 at 2017 MD&M West to see expanded portfolio of solutions and new capabilities for medical OEMs and pharmaceutical manufacturers




San Diego Plastic Surgeon Reveals Breast Augmentation Safety Tips

Tue, 24 Jan 2017 10:01:00 EST

Scott Miller, MD explains the benefits and risks of breast augmentation with implants, allowing his patients to make educated decisions about their health




DirectTrust Reports Record Growth in Direct Transactions, Number of Direct Exchange Addresses and Users

Tue, 24 Jan 2017 09:21:29 EST

Direct message transactions increased 146% during 2016




PharmaCyte Going Head to Head with Eli Lilly's Pancreatic Cancer Drug in New Clinical Trial

Tue, 24 Jan 2017 09:10:00 EST

NEW YORK, NY--(Marketwired - January 24, 2017) - Ten years ago the National Cancer Institute (NCI) recognized the rise in pancreatic cancer deaths and called for the development of better treatments. The NCI encouraged developers to design more clinical trials that don't use the chemotherapy drug gemcitabine as part of their treatment. PharmaCyte Biotech (OTCQB: PMCB) is on the doorstep of doing just that -- developing a treatment that doesn't use gemcitabine, and instead the company has designed a clinical trial that will actually go head to head with gemcitabine.




Vecna and The Advisory Board Company Announce Transition of Quality Compass

Tue, 24 Jan 2017 09:00:00 EST

CAMBRIDGE, MA--(Marketwired - Jan 24, 2017) - Vecna and the Advisory Board Company (ABC) together have announced that they will transition their real-time electronic infection surveillance and pharmacy solution, Quality Compass, to be fully supported, and marketed by Vecna's Patient Solutions business unit. ABC's Quality Compass product package is built using Vecna's QC PathFinderT, a software platform which integrates with a facility's healthcare IT ecosystem to predict, track, respond to, and report on hospital-acquired infections in real-time.




VPR Brands, LP will be participating at TPE Tobacco Plus Expo in Las Vegas showcasing their newest products for 2017

Tue, 24 Jan 2017 09:00:00 EST

FORT LAUDERDALE, FL--(Marketwired - Jan 24, 2017) - VPR Brands, LP (OTC PINK: VPRB) is proud to announce its participation in the TPE Tobacco Plus Expo booth# 6053, in Las Vegas, Nevada on January 25-26th. Nevada just recently voted to legalize marijuana for recreational use and the TPE show is the 1st major industry trade show to take place there since.




Propanc Provides Progress Update on Additional Patent Applications

Tue, 24 Jan 2017 08:30:00 EST

MELBOURNE, AUSTRALIA--(Marketwired - January 24, 2017) - Propanc Health Group Corporation (OTCQB: PPCH) ("Propanc" or "the Company"), an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, today announced an update on the progress of additional pending patent applications, since the recent allowance of the Company's first key patent application in the US this year.




Viveve Announces Additional Regulatory Approval in Southeast Asia

Tue, 24 Jan 2017 08:28:00 EST

SUNNYVALE, CA--(Marketwired - January 24, 2017) - Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE), a medical technology company focused on women's health, today announced that the company has received regulatory approval for the Viveve® System in Malaysia. The Viveve® System is cleared for marketing as a treatment of the vaginal introitus after vaginal childbirth to improve sexual function.




National Summit Explores Innovative Healthcare Payment Models

Tue, 24 Jan 2017 08:00:00 EST

WASHINGTON, DC--(Marketwired - January 24, 2017) - Amid debate over the future direction of healthcare policy under the Trump Administration, the National Payment Innovation Summit, scheduled for Feb. 8-10, 2017, in Dallas, Texas, reaffirms the fundamental shift of the healthcare industry toward value-based payment.




Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance

Tue, 24 Jan 2017 07:30:00 EST

Projects Positive Cash Flow by Mid 2017




Delivra Announces Distribution Agreement for its Opioid-Free LivRelief Products Using a Revolutionary Single Dose Delivery Packaging Platform

Tue, 24 Jan 2017 07:00:00 EST

TORONTO, ON--(Marketwired - January 24, 2017) - Delivra Corp. (TSX VENTURE: DVA) ("Delivra" or the "Company") subsidiary LivCorp Inc. announced today a new distribution agreement with Spike Marks Inc. ("Spike") for the launch of its three Over-the-Counter products in a simple and revolutionary single dose travel size.

With this agreement, consumers will see new 1.5g single-use sachets of the rapidly growing LivRelief Pain Relief Cream, LivRelief Nerve Pain Cream and LivRelief Healing Cream available in convenience stores throughout Canada. This will add to the LivRelief successful brand awareness strategy for both its natural and pharmaceutical products.




Longtime SCE Employee's Daughter Needs a Kidney Transplant

Mon, 23 Jan 2017 19:05:14 EST

LOS ANGELES, CA--(Marketwired - Jan 23, 2017) - Edison International is helping the daughter of its long-time employee, Annette Ramos, find a kidney. After six years on the waiting list, Annette Ramos' daughter's best chance is a living donor.




C.R. Bard, Medikit Lead Japan Vascular Access Market Fueled by Switch from Central Venous to Peripherally Inserted Central Catheters

Mon, 23 Jan 2017 13:24:55 EST

The increasing prevalence of diseases and conditions that require long-term vascular access is fueling the increased use of vascular access devices and is expected to be a driving factor in the Japanese market




Lice Clinics of America Opens New Treatment Center in Bellingham

Mon, 23 Jan 2017 11:00:00 EST

Clinic provides guaranteed, one-and-done lice treatments using FDA-cleared medical device




Arch Therapeutics to Present at Noble Financial Capital Markets' Thirteenth Annual Equity Conference

Mon, 23 Jan 2017 09:44:58 EST

FRAMINGHAM, MA--(Marketwired - Jan 23, 2017) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5T devices for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, announced that it will be featured as a presenting company at NobleCon13: Noble Financial Capital Markets' Thirteenth Annual Equity Conference in Boca Raton, Florida.




Allsup Cites New Study Tying Depression To Poorer Chemotherapy Outcomes In Lung Cancer Patients

Mon, 23 Jan 2017 09:30:00 EST

Findings underscore the need to document both physical and psychological impacts from chronic illness when individuals apply for Social Security Disability Insurance benefits




Advantis Corp. Developing Rosin Press for Home Use

Mon, 23 Jan 2017 09:26:00 EST

NEWPORT BEACH, CA--(Marketwired - Jan 23, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is currently developing a rosin press designed for home use. The company is adding to its current line up of rosin presses, and is in negotiations to have a well known personality in the cannabis industry represent the Advantis products.




PHZIO Telehealth Marketing Campaign

Mon, 23 Jan 2017 09:00:00 EST

CULVER CITY, CA--(Marketwired - Jan 23, 2017) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company has begun direct marketing telephone and email campaigns to multi-clinical PT practices throughout the state of California. The Company has also launched procative marketing campaigns to nationwide PT's on LinkedIn and Facebook. The Company also successfully held its initial webinar last week. Please see the following link to view this webinar: https://wnarchives.s3.amazonaws.com/45426582/62c11c14-baa2-4ad7-b8cd-521b38fd3542/archive.mp4. We also recently updated our PHZIO website that is available at: https://www.phzio.com




Starkey Hearing Technologies Launches Nearly Invisible Made for iPhone Device, TruLink(R) 4.0, Rechargeable ZPower(R) Muse(TM) Hearing Aid SurfLink(R) Mini Mobile and Acuity(TM) OS 2

Mon, 23 Jan 2017 09:00:00 EST

Revolutionary technology advances offer better sound, more personalized control and easier fittings




GeoVax Announces Initiation of HIV Human Clinical Trial

Mon, 23 Jan 2017 09:00:00 EST

ATLANTA, GA--(Marketwired - Jan 23, 2017) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today the initiation of the next human clinical trial of GeoVax's preventive HIV vaccine, GOVX-B11. The Phase 1 trial (designated HVTN 114) is being conducted by the HIV Vaccine Trials Network (HVTN) and is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).




Off The Scale Named as One of The Most Promising Population Health Management Solution Providers of 2017

Mon, 23 Jan 2017 09:00:00 EST

Health Tech Outlook Magazine recognizes Off The Scale ("OTS") for its achievements in slowing, stopping and reversing lifestyle-based chronic disease in PHM cohorts




Ritter Pharmaceuticals Announces Collaboration with University of Nebraska to Explore Development of Microbiome Therapeutics in Metabolic Syndrome

Mon, 23 Jan 2017 09:00:00 EST

LOS ANGELES, CA--(Marketwired - Jan 23, 2017) - Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or the "Company"), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced that it is collaborating with the newly-established Food for Health Center at the University of Nebraska ("NU") to study the role of the microbiome and RP-G28 in metabolic syndrome.




Zenosense, Inc.: New Patent Application for Additional MIDS Detection Method

Mon, 23 Jan 2017 08:30:00 EST

VALENCIA, SPAIN--(Marketwired - Jan 23, 2017) -  Zenosense, Inc. (OTCQB: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and commercialization of MIDS CardiacT, a Point of Care ("POC") handheld device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis, treatment and disposition of patients reporting chest pain and with suspected acute myocardial infarction (heart attack), is pleased to announce that MIDS Medical Limited ("MML"), our 40% owned joint venture based at Sci-Tech, Daresbury, UK has submitted a UK Intellectual Property Office patent application for an additional MIDS detection method.




Easton Pharmaceuticals Signs Letter Of Intent to Acquire Major Vaporizer and e-Liquids Manufacturer iBliss Inc.

Mon, 23 Jan 2017 08:00:00 EST

iBliss's Current Sales Are In the Millions Of Dollars and Are Projected To Quickly Reach and Surpass $15,000,000 in Sales With Healthy Profit Margins in Excess of 40%




GoodRx and Triplefin Partner to Provide Co-Pay Assistance Programs to Consumers

Mon, 23 Jan 2017 07:00:00 EST

SANTA MONICA, CA and CINCINNATI, OH--(Marketwired - January 23, 2017) - GoodRx, America's #1 source for prescription prices and savings, and Triplefin, an industry leader in providing pharmaceutical hub services, including patient access and adherence solutions, today announced an innovative partnership to provide manufacturer prescription co-pay savings coupons to GoodRx's five million unique monthly visitors.




Medigus Receives First Purchase Order for MUSE in Italy

Mon, 23 Jan 2017 07:00:00 EST

OMER, ISRAEL--(Marketwired - Jan 23, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that it received the first purchase order (PO) for the MUSET system in Italy from INNOVAMEDICA S.p.A, a privately-owned distributor of minimally invasive medical devices, in accordance with their existing distribution agreement.




Omni Health, Inc. Reports $1.0M Net Income and a $1.6M Consolidated Proforma Income for 1st Quarter of Fiscal Year 2017

Mon, 23 Jan 2017 07:00:00 EST

MIAMI, FL--(Marketwired - Jan 23, 2017) - Omni Health, Inc. (OTC PINK: OMHE), a pharmaceutical company, filed today its first quarter results for fiscal year 2017, ending July 31, 2016. OMHE recorded a $1.08M net income, which incorporated Malecon Pharmacy, Inc., a wholly owned subsidiary of OMHE as of June 22, 2016. In addition to the results, and in accordance with ASC 805-10-50, the Company provided the results of net income of the combined results of the Company's consolidated operations with the acquisition as if the acquisition had been completed as of the beginning of the reporting period. As such, the proforma results was $1.6M Net Income. The Company recognized a one-time sale of discontinue operations of VitaCig to mCig, Inc. (OTC: MCIG), in the amount of $1.1M leaving a $500K adjusted proforma net income for the consolidated quarter.




Stewart to Teach First-Ever Health Care Law Class at University of Denver Sturm College of Law

Fri, 20 Jan 2017 14:50:11 EST

DENVER, CO--(Marketwired - January 20, 2017) - Spencer Fane LLP is happy to announce that Partner Ellen E. Stewart is teaching a course on health care law at the University of Denver Sturm College of Law Spring 2017. The course is the first of its kind at Denver Law, providing an in-depth exploration of the legal issues bounding health care, and how these laws shape the industry.




Ubiquitech Software Corp. Announces Earnings Release Date and First Shareholder Conference Call

Fri, 20 Jan 2017 12:36:54 EST

DENVER, CO--(Marketwired - Jan 20, 2017) - Ubiquitech Software Corp. (OTC PINK: UBQU) is pleased to announce that it will be releasing earnings results on Thursday, January 26th. Following the close of market the company will also be holding an investor conference call at 4:30PM EST.




Navy Vet Celebrates 100th Birthday by Finishing Cancer Treatments

Fri, 20 Jan 2017 11:00:00 EST

Scripps proton therapy allows Carlsbad man to maintain active lifestyle




Servier Appoints MaSTherCell for the Development of its CAR-T Cell Therapy Manufacturing Platform

Fri, 20 Jan 2017 09:00:00 EST

GERMANTOWN, MD--(Marketwired - Jan 20, 2017) -   Orgenesis Inc. (OTCQB: ORGS), a fully-integrated cell therapy and contract development and manufacturing company, announced that its wholly-owned subsidiary, MaSTherCell S.A., specializing in the delivery of optimized process industrialization capacities to cell therapy organizations, has signed a master service agreement with Servier for the development of a manufacturing platform for allogeneic cell therapies. Under the master service agreement, MaSTherCell is developing a CAR-T cell therapy manufacturing platform, which will enable industrial and commercial manufacturing of Servier's cell therapy products. This is a critical step in the development of these products for later stage clinical trials.




Rennova Health's Pharmacogenomics Subsidiary Granted Patent

Fri, 20 Jan 2017 08:30:00 EST

WEST PALM BEACH, FL--(Marketwired - January 20, 2017) - Rennova Health, Inc. (NASDAQ: RNVA), (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that its Genomas, Inc. pharmacogenomics subsidiary has been granted a Patent by the US Patent and Trademark Office.




Newly Created Standards Coordinating Body Seeks to Advance Development and Establishment of Regenerative Medicine Standards

Thu, 19 Jan 2017 15:23:19 EST

Builds upon call for standards development in 21st Century Cures Act




GetWellNetwork Acquires Seamless Medical Systems, Extends Reach to More Than 150 Clinics

Thu, 19 Jan 2017 15:00:00 EST

Company's third acquisition in 30 months expands impact of patient engagement to millions of patients and families across care continuum




Austin, Houston, and Dallas Hair Transplant Surgeon Discusses Options for Transgender Patients

Thu, 19 Jan 2017 14:29:26 EST

With hair transplant surgery, Dr. Bernardino Arocha says he can help both male-to-female (MTF) and female-to-male (FTM) transgender patients better express their gender identity




The Alliance for Regenerative Medicine Launches Standards Coordinating Body to Advance Development and Establishment of Industry-Wide Standards

Thu, 19 Jan 2017 12:22:41 EST

Builds upon call for standards development in 21st Century Cures Act




Lice Clinics of America Treatment Center Under New Ownership in Palm Beach County, FL

Thu, 19 Jan 2017 10:36:39 EST

The only Lice Clinic to offer guaranteed, one-and-done lice treatments using the FDA-cleared AirAllé medical device




Somnia Anesthesia Hosts Its CRNA of the Year Contest During CRNA Week

Thu, 19 Jan 2017 10:00:00 EST

Nominations for Somnia's Sixth Annual CRNA of the Year Award Now Open







Vaxil Bio Expands Into Infectious Diseases With First US Patent for MTbuVax(TM)

Thu, 19 Jan 2017 09:30:00 EST

Receives USPTO Notice of Allowance for MTbuVax(TM) Family of Signal Peptide Vaccines and their use in Treating Major Infectious Diseases




Invictus MD Strategies Outlines Vision in Exclusive Interview with CFN

Thu, 19 Jan 2017 09:15:00 EST

SEATTLE, WA--(Marketwired - Jan 19, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article and interview discussing recent developments and the path forward for Invictus MD Strategies Inc. (CSE: IMH) (OTC PINK: IVITF).




AssistRx Acquires Caret(TM), Providing Users with Cutting Edge Technology to Boost Patient Care Management, Adherence, and Compliance

Thu, 19 Jan 2017 09:01:00 EST

ORLANDO, FL--(Marketwired - Jan 19, 2017) -  AssistRx (ARx), the leading enterprise technology platform focused on simplifying the patient journey for specialty and highly-managed medications, today announces its acquisition of Caret, and Caret's Care Management Platform. Caret provides healthcare providers, specialty pharmacies, patients, and payers a best-in-class communication platform powered by actionable data such as point-of-service decision making, care management programs and near real-time updates on patients. ARx plans to integrate these features into the AssistRx Platform, to enhance the patient journey, drive quality-based healthcare, and improve outcomes.




InMed Pharma Appoints Eli Lilly Finance Executive to Board of Directors -- CFN Media

Thu, 19 Jan 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Jan 19, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing InMed Pharmaceuticals Inc.'s (OTCQB: IMLFF) (CNSX: IN) recent appointment of Martin Bott to its Board of Directors, the company's existing team, and what it means as InMed progresses towards its first clinical trial in INM-750 for the treatment of Epidermolysis Bullosa as well as the rest of its clinical pipeline.




AXIM Biotech Begins CanChew Plus Clinical Trials -- SECFilings.com

Thu, 19 Jan 2017 09:00:00 EST

REDONDO BEACH, CA--(Marketwired - Jan 19, 2017) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering AXIM® Biotechnologies Inc.'s (OTCQB: AXIM) recently announced clinical trials evaluating its CanChew Plus® cannabidiol (CBD) gum for the treatment of irritable bowel syndrome (IBS).




70% of Global Drug Safety Teams Outsource Case Management Activities

Thu, 19 Jan 2017 07:44:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - January 19, 2017) - Data published by pharmaceutical competitive intelligence firm Cutting Edge Information found that literature services are the most commonly outsourced item among 70% of surveyed pharmacovigilance teams.




Proto Script Pharmaceutical Corp. Building New Partnerships with Independent Practice Associations (IPA)

Thu, 19 Jan 2017 06:00:00 EST

RANCHO CUCAMONGA, CA--(Marketwired - Jan 19, 2017) - Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, today provided this update regarding its current business and future expansion plans with Independent Practice Associations.




PHZIO Telehealth Webinar Link

Wed, 18 Jan 2017 13:30:36 EST

CULVER CITY, CA--(Marketwired - Jan 18, 2017) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first telehealth company for physical therapy to offer insurance reimbursable remotely monitored physical therapy (PT) treatments. The Company successfully held its initial webinar this morning. Please see the following link to view this webinar: https://wnarchives.s3.amazonaws.com/45426582/62c11c14-baa2-4ad7-b8cd-521b38fd3542/archive.mp4. More information about our telehealth solution is available at our PHZIO.COM website: https://www.phzio.com




Megadyne Medical Named Utah's Most Innovative PR & Marketing Team 2016

Wed, 18 Jan 2017 13:00:00 EST

DRAPER, UT--(Marketwired - January 18, 2017) - Megadyne Medical Products, The Electrosurgical Authority® and full-solution electrosurgical provider, was recently named Utah's Most Innovative PR & Marketing Team 2016 by Corporate America News magazine. According to the online publication based in New York City, this prestigious award was granted to the medical device company based on its impressive presence across media, as well as client recommendations and referrals from other agencies who have witnessed the impact of Megadyne through its various PR and marketing initiatives.




Brown Technical Media Corp. Announces Uplist to the QB Tier of the OTC Markets

Wed, 18 Jan 2017 10:30:00 EST

HOUSTON, TX--(Marketwired - Jan 18, 2017) - Brown Technical Media Corp., a division of Panther Biotechnology Inc. (OTCQB: PBYA), an e-commerce company building the first full service training and career advancement brand for the skilled trades, is pleased to announce today that it has been accepted for up listing to the OTCQB effective immediately.




Premier Biomedical Pain Management Solutions Announces Product Distribution Agreement of Their Superior Pain Relief Products

Wed, 18 Jan 2017 10:15:00 EST

EL PASO, TX--(Marketwired - Jan 18, 2017) - Premier Biomedical, Inc. (OTCQB: BIEI) announced today their newly created joint venture company, Premier Biomedical Pain Management Solutions, LLC (PBPMS) has signed a distribution agreement contract with the Pain Relief & Wellness Strategy Center in Grove City, Pennsylvania to sell and distribute its pain relief products. Initially, the contract will cover pain relief patches and roll-ons, but will expand as new products are introduced.







Konica Minolta Healthcare Americas Partners with 7Dimaging to Strengthen its Educational Offering

Wed, 18 Jan 2017 09:40:00 EST

WAYNE, NJ--(Marketwired - January 18, 2017) - Konica Minolta Healthcare Americas, Inc., a leading provider in musculoskeletal ultrasound (MSK), has partnered with 7Dimaging to strengthen its educational resources by offering the mskNAVT Education Tool.




Beazley adds life sciences underwriter in San Francisco

Wed, 18 Jan 2017 09:02:41 EST

SAN FRANCISCO, CA--(Marketwired - January 18, 2017) - Beazley, a leading provider of specialist miscellaneous medical insurance, has strengthened its miscellaneous medical underwriting team with the hire of life sciences underwriter Marc Amis in its San Francisco office. This is the latest addition to Beazley's growing team addressing the needs of organizations across the healthcare industry, with a focus on hard to place risks.




Medical Marijuana Secures Partnership with Key Pharmaceutical Distributor -- CFN Media

Wed, 18 Jan 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Jan 18, 2017) -  CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Medical Marijuana Inc.'s (OTC PINK: MJNA) recent groundbreaking agreement with a South American pharmaceutical distributor and how the company aims to capitalize on the market.




Predictive Technology Group, Inc. (PRED) Reaches Key Clinical Milestone in Development of Genetic Tests for Infertility and Endometriosis

Wed, 18 Jan 2017 09:00:00 EST

Development of ARTGuide(R) Test Will Rapidly Accelerate Short-Term Company Growth




VPR Brands, LP will be Re-Launching the STINGER at the BIG Industry in Los Angeles California

Wed, 18 Jan 2017 08:30:00 EST

FORT LAUDERDALE, FL--(Marketwired - Jan 18, 2017) - VPR Brands, LP (OTC PINK: VPRB) is proud to announce its participation in the 2017 Big Industry Show in Los Angeles, California on January 19-20th where we will be showcasing our flagship product, the STINGER, part of our Honey Stick Brand.




Pharma Compliance Teams Approving Physician Compensation Cap Exceptions

Wed, 18 Jan 2017 08:17:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - January 18, 2017) - Although more pharmaceutical companies have instituted compensation limits as a response to scrutiny over their payments to physicians, there are still exceptions to those rules.




MediXall Appoints Dr. Pedro A. Sanchez, D.O., to be its First Medical Director

Wed, 18 Jan 2017 07:30:00 EST

FT. LAUDERDALE, FL--(Marketwired - Jan 18, 2017) - MediXall Group, Inc. (OTCQB: MDXL) is pleased to announce the appointment of its first Medical Director, Dr. Pedro A. Sanchez, D.O. Dr. Sanchez is a graduate of Southeastern College of Osteopathic Medicine in Ft. Lauderdale, Florida, and served his residency at Wellington Regional Medical Center in Wellington, Florida. Dr. Sanchez is Board Certified by the American Osteopathic Board of Family Physicians, and has been a successful family practice physician for over 25 years.




Omni Health, Inc. names Andrey Soloviev as New CEO

Wed, 18 Jan 2017 07:25:04 EST

MIAMI, FL--(Marketwired - Jan 18, 2017) -  Omni Health, Inc., (OTC PINK: OMHE), a pharmaceutical company, announced today the Board of Directors has selected Andrey Soloviev as its new Chief Executive Officer. Mr. Soloviev will take over, effective immediately, for interim CEO, Michael Hawkins, who shall remain the company's interim CFO.